Literature DB >> 7422124

Clinical dosimetry during cerebral arteriography.

M Chopp, H D Portnoy, R Schurig, P Croissant.   

Abstract

Radiation dosimetry measurements on angiographer, X-ray technician and patient were performed during 18 femerocerebral angiograms. Lithium fluoride (LiF) thermoluminescent dosimeters were placed on various body areas to measure X-ray exposure. The results of this study indicate that radiation exposure received by medical personnel are well within the maximum permissible dose range established by the National Council of Radiation Protection. However, radiation exposure levels to radiosensitive areas of the patient are significant. A method to reduce patient exposure during femerocerebral arteriograms is suggested.

Entities:  

Mesh:

Year:  1980        PMID: 7422124     DOI: 10.1007/bf00339550

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

1.  Dosimetry during cineradiography and other specialized radiographic diagnostic procedures.

Authors:  M P CAPP; M S SPACH
Journal:  Radiology       Date:  1962-05       Impact factor: 11.105

2.  Clinical dosimetry during the angiographic examination. Comments on coronary arteriography.

Authors:  M H Wholey
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

3.  The use of radiothermoluminescent dosimeters in the field of diagnostic radiology.

Authors:  S J Malsky; B Roswit; C B Reid; C G Amato; R Goebel
Journal:  Radiology       Date:  1968-03       Impact factor: 11.105

4.  Radiation exposure to personnel during cardiac catheterization. A preliminary study.

Authors:  S J Malsky; B Roswit; C B Reid; J Haft
Journal:  Radiology       Date:  1971-09       Impact factor: 11.105

  4 in total
  1 in total

1.  Radiation exposure to the primary operator during endovascular surgical neuroradiology procedures.

Authors:  K F Layton; D F Kallmes; H J Cloft; B A Schueler; G M Sturchio
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.